Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000223661 | SCV000277104 | likely benign | Hereditary cancer-predisposing syndrome | 2016-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV003743665 | SCV000562636 | likely benign | Familial adenomatous polyposis 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000223661 | SCV000681768 | likely benign | Hereditary cancer-predisposing syndrome | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679072 | SCV000805443 | likely benign | not provided | 2017-08-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987456 | SCV004803328 | likely benign | not specified | 2024-01-15 | criteria provided, single submitter | clinical testing |